Periodical
A consensus statement from the Portuguese Society of Hypertension and the Portuguese Society of Cardiology for bridging the 2023-2025 hypertension Guidelines in clinical practice.
| Τίτλος: | A consensus statement from the Portuguese Society of Hypertension and the Portuguese Society of Cardiology for bridging the 2023-2025 hypertension Guidelines in clinical practice. |
|---|---|
| Συγγραφείς: | Ribeiro H; Serviço de Medicina Interna, Unidade Local de Saúde de Entre Douro e Vouga. R. Dr. Cândido Pinho 5, Santa Maria da Feira, Portugal., Matos Vilela E; Serviço de Cardiologia, Unidade Local de Saúde de Gaia e Espinho. Rua Conceição Fernandes, Vila Nova de Gaia, Portugal.; Departamento de Medicina, Faculdade de Medicina da Universidade do Porto. Alameda Prof. Hernâni Monteiro, Porto, Portugal., Martos Gonçalves F; Serviço de Medicina Interna, Hospital Beatriz Ângelo, Unidade Local de Saúde Loures, Odivelas, Avenida Carlos Teixeira, 3. Loures, Portugal., Gavina C; Departamento de Medicina, Faculdade de Medicina da Universidade do Porto. Alameda Prof. Hernâni Monteiro, Porto, Portugal.; Serviço de Cardiologia, Unidade Local de Saúde de Matosinhos, Senhora da Hora, Portugal.; UnIC, Faculdade de Medicina, Universidade do Porto. Al. Prof. Hernâni Monteiro, Porto, Portugal., de Pinho R; USF Vale do Vouga, Unidade Local de Saúde Entre Douro e Vouga, São João da Madeira, Portugal. |
| Πηγή: | Blood pressure [Blood Press] 2026 Dec; Vol. 35 (1), pp. 2624257. Date of Electronic Publication: 2026 Feb 13. |
| Τύπος έκδοσης: | News |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9301454 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1651-1999 (Electronic) Linking ISSN: 08037051 NLM ISO Abbreviation: Blood Press Subsets: MEDLINE |
| Imprint Name(s): | Publication: 2015- : Abingdon, Oxford : Taylor & Francis Original Publication: Oslo : Scandinavian University Press |
| Ιατρικοί όροι (MeSH): | Antihypertensive Agents*/therapeutic use , Hypertension*/drug therapy , Hypertension*/physiopathology , Hypertension*/therapy , Hypertension*/diagnosis , Consensus Statements as Topic*, Blood Pressure/drug effects ; Humans ; Cardiology ; Portugal ; Societies, Medical |
| Περίληψη: | Background: Effective management of arterial hypertension remains a major global health priority. In the need to improve real-world implementation of best practices, three international organisations have released independent clinical practice guidelines: the European Society of Hypertension (ESH, 2023), the European Society of Cardiology (ESC, 2024) and the American College of Cardiology/American Heart Association (AHA/ACC, 2025).1. Aim and Methods: This society-endorsed consensus document, jointly developed by the Portuguese Society of Hypertension and the Portuguese Society of Cardiology, aims to harmonise partially divergent hypertension guidelines into applicable recommendations. It provides a pragmatic comparative synthesis of the 2023-2025 guidelines, structured according to the M.A.P.E. framework (Measure, Assess, Prescribe, Evaluate), to support decision-making in clinical practice. Results: Across European guidelines, there is a strong alignment in the definition of hypertension (systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg), CV risk stratification, lifestyle interventions, and first-line use of combination therapy of two drugs out of four. Divergences arise in BP classification systems, initiation thresholds, dosing strategies and target BP goals. The 2025 AHA/ACC Guidelines differ by adopting lower diagnostic and treatment thresholds (≥130/80 mmHg) and early pharmacological intervention based on individual CV risk. This consensus acknowledges differences and supports a risk-based approach grounded in randomised trial evidence, feasibility in routine clinical practice, and patient safety, recognising office BP as the basis for treatment decisions. Conclusions: This consensus aims to reduce clinical uncertainty and optimise hypertension management in real-world practice providing clear and evidence-informed clinical recommendations. |
| Σχόλια: | Erratum in: Blood Press. 2026 Dec;35(1):2647700. doi: 10.1080/08037051.2026.2647700.. (PMID: 41886763) |
| Contributed Indexing: | Keywords: Blood pressure; antihypertensive drug therapy; cardiovascular disease; clinical recommendations; consensus; guidelines; hypertension; management of arterial hypertension Local Abstract: [plain-language-summary] High blood pressure, also called hypertension, is one of the most common health problems worldwide. It greatly increases the risk of heart and kidney disease. To help doctors and patients manage hypertension effectively, several international organisations regularly update their treatment recommendations, known as clinical guidelines.This article summarises and compares the most recent guidelines from three major scientific organisations: the European Society of Hypertension (ESH, 2023), the European Society of Cardiology (ESC, 2024), and the American College of Cardiology/American Heart Association (AHA/ACC, 2025). Although these guidelines share the same goal – improving blood pressure control and preventing heart, brain and kidney complications – they differ in certain clinical details, such as when to start medication, how much to lower blood pressure, and the targets to achieve.This consensus document, developed by the Portuguese Society of Hypertension and the Portuguese Society of Cardiology, combines different guidelines on high blood pressure to offer clear and practical advice for everyday patient care.The European guidelines agree on defining hypertension as blood pressure at or above 140/90 mmHg. They also recommend lifestyle changes, regular monitoring, and the use of the same main types of blood pressure-lowering medicines. In contrast, the American guidelines use lower thresholds (from 130/80 mmHg) and encourage earlier medicine treatment in people at higher cardiovascular risk.The Portuguese consensus acknowledges these differences and supports a risk-based approach that is based on results from clinical trials, is practical for everyday care, and prioritises patient safety, using blood pressure measured in the clinic to guide treatment decisions.By bringing together European and American guidelines, this Portuguese consensus aims to reduce uncertainty for healthcare professionals and help improve the everyday management of high blood pressure through well-defined and practical recommendations. |
| Substance Nomenclature: | 0 (Antihypertensive Agents) |
| Entry Date(s): | Date Created: 20260129 Date Completed: 20260701 Latest Revision: 20260707 |
| Update Code: | 20260708 |
| DOI: | 10.1080/08037051.2026.2624257 |
| PMID: | 41607194 |
| Βάση Δεδομένων: | MEDLINE |
| ISSN: | 1651-1999 |
|---|---|
| DOI: | 10.1080/08037051.2026.2624257 |